regenerative-medicine
The Lipogems system, patented by Prof. Tremolada in 2010, is an FDA-cleared advanced technology that utilizes the patient's adipose cells to support the healing process. It is currently present in dozens of countries and is used by highly qualified orthopedic surgeons and physicians affiliated with major universities and private clinics.
Adipose tissue contains one hundred to five hundred times more reparative cells compared to other similar tissues. Adipose cells are easy to harvest from the patient and present minimal risk of rejection and infection. The technology is particularly indicated for patients affected by:
- Degenerative processes of articular cartilage (degenerative chondropathy) - Meniscal degeneration and inflammatory lesions - Problems affecting tendon and ligament structures - Sports-related joint injuries
The procedure takes approximately one hour and involves: 1. Harvesting adipose tissue (usually from abdomen or flanks) 2. Minimal processing in closed system with saline solution 3. Micro-fragmentation of tissue 4. Infiltration into target areas under ultrasound guidance
Lipogems technology is supported by solid scientific and clinical evidence. As emphasized by Dr. Kennedy from the Hospital for Special Surgery in New York, patients are entered into a database to continuously evaluate outcomes. Research continues to explore the potential of this technology in regenerative medicine.
It is essential to rely only on qualified orthopedic physicians and verify that the technology used is FDA-approved. Patients should be wary of clinics offering uncertified stem cell treatments or miraculous promises of cartilage regrowth.